Patent · US Active

Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles

US8465767B2 · kind B2 · utility

0Cited by

14References

21Claims

0Family size

Assignee

TAKEDA GMBH · DE

Inventors

Rango Dietrich · Konstanz, DE
Hartmut Ney · Konstanz, DE

Key dates

Filing date	May 21, 2008
Grant date	Jun 18, 2013
Priority date	—
Expiry date	Jan 29, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.